gewonnene oder verlorene Zeit?

Doktorate an Medizinischen Universitäten:
gewonnene oder verlorene Zeit
Stefan Boehm
Abteilung für Neurophysiologie und –pharmakologie
Zentrum für Physiologie und Pharmakologie
Curriculumdirektor für die Doktoratsstudien

‚Whining PhD students are nothing new, but there seem to be genuine problems
with iththe system that tproduces research hdoctorates t (the practical l“ “professional
doctorates” in fields such as law, business and medicine have a more obvious
value).‘ (The Economist, Dec 2010)
‚PhD programmes in the sciences still overemphasize the academic
track and actively devalue other career paths.‘ (Nature 472, April 2011)

N094
N790
“Science as profession”
“Science in profession”

Equivalence of N094 and N790

Qualification profile N094

Qualification profile N790

Courses and ECTS credits
N094
N790

Propedeutics
general
knowledg
ge and transfera
able skills

Doctoral curricula,
students, and graduates
(since 2004)
936 doctoral students, 184 doctoral graduates
Doctoral Program of Medical Sciences
86 students, 109 graduates
PhD Program
501 students, 70 graduates
Doctoral Program of Applied Medical Sciences
386 students, 5 graduates
number of thes sis submissions pe er month
10
8
6
4
2
0
2007 2008 2009 2010 2011
month
number of the esis defenses per
10
8
6
4
2
0
2007 2008 2009 2010 2011

Doctoral students
Medical Sciences
PhD
Applied Medical Sciences
International
Austrian
0 20 40 60 80 100
% of students
0 20 40 60 80 100
% of students
0 20 40 60 80 100
% of students
Non-Medical
Medical
0 20 40 60 80 100
% of students
0 20 40 60 80 100
% of students
0 20 40 60 80 100
% of students

6 Doctoral programs
funded by
Molecular Drug Targets

CCHD
Cell
Communication
in
Health and Disease
A doctoral programme supported by
the Austrian Science Fund (FWF),
the Medical University of Vienna (MUW),
and the Center for Molecular Medicine (CeMM)
Coordinator: Sylvia Knapp

priority areas of research at the MUW
Allergology / Immunology / Infectious diseases
Oncology
Neuroscience
Vascular Biology
Organ failure and replacement
Inflammation
Public health
Basic medical and diagnostic research
Intensive care research
Metabolism (and nutrition)
Cell
Communication in
Health and
Disease

topics and supervisors of CCHD
Immunology
Erika Jensen-Jarolim:
immunity towards oral antigens
Sli Sylvia Knapp:
innate immunity and bacterial infection
Hannes Stockinger:
T cell activation in real-time
Giulio Superti-Furga:
signalling pathway proteomics
Vascular Biology
Margarethe Geiger:
serine proteases and coagulation
Dontscho Kerjaschki:
lymphatic endothelial cells
Christine Mannhalter:
pathogenic mechanisms in thrombotic diseases
Neurobiology
Inflammation
Stefan Boehm:
Hans Lassmann:
mechanisms of presynaptic modulation pathogenic mechanisms in multiple sclerosis
Michael Freissmuth:
GPCRs and neurotransmitter transporters
Thomas Klausberger:
molecular machineries in cortical networks
Werner Sieghart:
GABA A receptor structure and function
Cell
Communication in
Health and
Disease
Thomas Stulnig:
mechanisms of adipose tissue inflammation
Oswald Wagner:
inflammation in atherosclerosis

major assets of CCHD
internationally visible graduate programme
multidisciplinary approach to study cell communication as basis for
improved understanding of disease mechanisms and drug
target identification/validation
network of open laboratories with daily interactions
training of excellent graduate students in medically relevant signal
transduction research and in a broad range of advanced
techniques
integrated interdisciplinary teaching programme
international exposure of the graduate students
Cell
Communication in
Health and
Disease

application-oriented further training
(propedeutics)
GSP and Ethics in Science
(Ernst Singer, chairman of the Ethics Committee at the MUW)
research in the pharmaceutical industry, GMP, GLP
(Peter Turecek, senior dirctor R&D, Baxter, Austria)
GCP and medical statistics
(Sandor Fritsch, ,g global director statistics, Baxter, Austria)
project management
(Rudolf Widman, CEO of Austrian Orphan Pharmaceuticals)
intellectual property rights
(Harald Nemec, European Patent Attorney Company)
scientific English, communication and funding
(Edda Fiebiger, Children‘s Hospital, Boston, USA)
basics of bioinformatics (Jacques Colinge, CeMM)
basic infection biology (Sylvia Knapp, CeMM)

For further information see
www.phd-cchd.at

previous doctoral students
of the neuropharmacology group
Nina Vartian
Ursula Unterberger
Thomas Scholze
Stefan Lechner
Hanna Edelbauer
Simon Hussl
Mario Dorostkar
Klaus Schicker
Kristina Kosenburger
Felicia Klinger
AOP Orphan Pharmaceuticals
Clinical Institute of Neurology; AKH
Baxter Austria
Max-Delbrück-Center for Molecular Medicine, Berlin
KAV
Der Drink
Center for Neuropathology, Ludwig-Maximilians-Univ. München
Center for Physiology and Pharmacology, Medical Univ. Vienna
Agneter Pharmaconsulting
Clinic for Radiology, AKH
aop orphan